ondansetron and mdl 100907

ondansetron has been researched along with mdl 100907 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aoyama, T; Hattori, T; Kato, S; Kurosawa, S; Nahata, M; Ohno, S; Ro, S; Sakurada, T; Takabayashi, H; Tamai, M; Yakabi, K; Yuzurihara, M1
Gerlai, R; Markovic, S; Muraleetharan, A; Nowicki, M; Tran, S1

Other Studies

2 other study(ies) available for ondansetron and mdl 100907

ArticleYear
Rikkunshito and 5-HT2C receptor antagonist improve cisplatin-induced anorexia via hypothalamic ghrelin interaction.
    Regulatory peptides, 2010, Apr-09, Volume: 161, Issue:1-3

    Topics: Animals; Anorexia; Cisplatin; Drugs, Chinese Herbal; Eating; Gastric Mucosa; Ghrelin; Granisetron; Hypothalamus; Male; Oligopeptides; Ondansetron; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Ghrelin; Reverse Transcriptase Polymerase Chain Reaction; Serotonin 5-HT2 Receptor Antagonists; Stomach

2010
Serotonin antagonists induce anxiolytic and anxiogenic-like behavior in zebrafish in a receptor-subtype dependent manner.
    Pharmacology, biochemistry, and behavior, 2014, Volume: 126

    Topics: Aminopyridines; Animals; Anti-Anxiety Agents; Anxiety; Benzamides; Ketanserin; Ondansetron; Piperazines; Pyridines; Receptors, Serotonin; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin 5-HT3 Receptor Antagonists; Zebrafish

2014